|Articles|May 1, 2002
Glaucoma drug lowers IOP for up to 84 hours, study finds
Morrow, GA-Effective treatment of open-angle glaucoma requires not only the lowering of IOP but maintenance of the low pressure around the clock.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient
2
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
3
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
4
Q&A: Advancing a long-acting anti-VEGF candidate: What it means for retinal disease
5














































.png)


